The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming
Open accessAbstract
The cyclic oligosaccharide 2-hydroxypropyl-β-cyclodextrin facilitates atheroprotective mechanisms through oxysterol-mediated reprogramming of macrophages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Maere, S., Heymans, K., & Kuiper, M. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti551 · Cited by 4,155
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 2×
“CCs can trigger complement activation and neutrophil extracellular trap (NET) formation, as well as induction of innate immune pathways ( 4 , 5 , 8 – 10 ).”
BackgroundSelf-citationHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Self-citationEfficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
Robinson, J. G., Farnier, M., Krempf, M., Bergeron, J., Luc, G., Averna, M., Stroes, E. S., Langslet, G., Raal, F. J., El Shahawy, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501031 · Cited by 2,296
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Merico, D., Isserlin, R., Stueker, O., Emili, A., & Bader, G. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013984 · Cited by 2,235
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
Khera, A. V., Cuchel, M., de la Llera-Moya, M., Rodrigues, A., Burke, M. F., Jafri, K., French, B. C., Phillips, J. A., Mucksavage, M. L., Wilensky, R. L., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1001689 · Cited by 1,943 · cited 1×
“Hence, CD treatment increased the cholesterol efflux capacity of macrophages, which represents an important protective factor in patients with coronary artery disease (25, 26).”
BackgroundAn oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591
Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
Sabatine, M. S., Giugliano, R. P., Wiviott, S. D., Raal, F. J., Blom, D. J., Robinson, J., Ballantyne, C. M., Somaratne, R., Legg, J., Wasserman, S. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500858 · Cited by 1,509
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Self-citationHDL cholesterol efflux capacity and incident cardiovascular events
Rohatgi, A., Khera, A., Berry, J. D., Givens, E. G., Ayers, C. R., Wedin, K. E., Neeland, I. J., Yuhanna, I. S., Rader, D. R., de Lemos, J. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409065 · Cited by 1,390
Regulation of Absorption and ABC1-Mediated Efflux of Cholesterol by RXR Heterodimers
Repa, J. J., Turley, S. D., Lobaccaro, J.-M. A., Medina, J., Li, L., Lustig, K., Shan, B., Heyman, R. A., Dietschy, J. M., & Mangelsdorf, D. J. (2000) · Science · doi:10.1126/science.289.5484.1524 · Cited by 1,301
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Warnatsch, A., Ioannou, M., Wang, Q., & Papayannopoulos, V. (2015) · Science · doi:10.1126/science.aaa8064 · Cited by 1,270
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
Joseph, S. B., McKilligin, E., Pei, L., Watson, M. A., Collins, A. R., Laffitte, B. A., Chen, M., Noh, G., Goodman, J., Hagger, G. N., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112059299 · Cited by 947
Sheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
Self-citationRidker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Brott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. B., Friday, G., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820d8d78 · Cited by 797
Cyclodextrins in drug delivery
Loftsson, T., Jarho, P., Másson, M., & Järvinen, T. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.335 · Cited by 793
2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review
Gould, S., & Scott, R. C. (2005) · Food and Chemical Toxicology · doi:10.1016/j.fct.2005.03.007 · Cited by 746
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides
Rayner, K. J., Esau, C. C., Hussain, F. N., McDaniel, A. L., Marshall, S. M., van Gils, J. M., Ray, T. D., Sheedy, F. J., Goedeke, L., Liu, X., et al. (2011) · Nature · doi:10.1038/nature10486 · Cited by 706
Rayner, K. J., Sheedy, F. J., Esau, C. C., Hussain, F. N., Temel, R. E., Parathath, S., van Gils, J. M., Rayner, A. J., Chang, A. N., Suarez, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57275 · Cited by 690 · cited 1×
“We adapted a less invasive regression protocol (20) in which ApoEmice were first fed a cholesterol-rich diet for 8 weeks to induce advanced atherosclerotic lesions and then switched to a normal chow diet for another 4 weeks during which CD or vehicle control was administered (Fig.”
MethodLütjohann, D., Breuer, O., Ahlborg, G., Nennesmo, I., Sidén, A., Diczfalusy, U., & Björkhem, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9799 · Cited by 682
Self-citationAnimal Models of Atherosclerosis
Getz, G. S., & Reardon, C. A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.237693 · Cited by 630
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications
Tabas, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16452 · Cited by 598
Mathiesen, E. B., Bønaa, K. H., & Joakimsen, O. (2001) · Circulation · doi:10.1161/01.cir.103.17.2171 · Cited by 573
Consequences of cellular cholesterol accumulation: basic concepts and physiological implications
Tabas, I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216452 · Cited by 540
Castrillo, A., Joseph, S. B., Vaidya, S. A., Haberland, M., Fogelman, A. M., Cheng, G., & Tontonoz, P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00384-8 · Cited by 488
De Nardo, D., Labzin, L. I., Kono, H., Seki, R., Schmidt, S. V., Beyer, M., Xu, D., Zimmer, S., Lahrmann, C., Schildberg, F. A., et al. (2014) · Nature Immunology · doi:10.1038/ni.2784 · Cited by 462
Self-citation25-Hydroxycholesterol suppresses interleukin-1–driven inflammation downstream of type I interferon
Reboldi, A., Dang, E. V., McDonald, J. G., Liang, G., Russell, D. W., & Cyster, J. G. (2014) · Science · doi:10.1126/science.1254790 · Cited by 444
Mayor, A., Martinon, F., De Smedt, T., Pétrilli, V., & Tschopp, J. (2007) · Nature Immunology · doi:10.1038/ni1459 · Cited by 440
The liver X receptor gene team: Potential new players in atherosclerosis
Repa, J. J., & Mangelsdorf, D. J. (2002) · Nature Medicine · doi:10.1038/nm1102-1243 · Cited by 388
Cholesterol Crystals Induce Complement-Dependent Inflammasome Activation and Cytokine Release
Samstad, E. O., Niyonzima, N., Nymo, S., Aune, M. H., Ryan, L., Bakke, S. S., Lappegård, K. T., Brekke, O.-L., Lambris, J. D., Damås, J. K., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302484 · Cited by 289
Self-citationLive Cell Multicolor Imaging of Lipid Droplets with a New Dye, LD540
Spandl, J., White, D. J., Peychl, J., & Thiele, C. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00980.x · Cited by 246
Feig, J. E., Pineda-Torra, I., Sanson, M., Bradley, M. N., Vengrenyuk, Y., Bogunovic, D., Gautier, E. L., Rubinstein, D., Hong, C., Liu, J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci38911 · Cited by 185
Wassmann, S., Bäumer, A. T., Strehlow, K., van Eickels, M., Grohé, C., Ahlbory, K., Rösen, R., Böhm, M., & Nickenig, G. (2001) · Circulation · doi:10.1161/01.cir.103.3.435 · Cited by 181
Self-citationCyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells.
Atger, V. M., de la Llera Moya, M., Stoudt, G. W., Rodrigueza, W. V., Phillips, M. C., & Rothblat, G. H. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119223 · Cited by 176
WordCloud: a Cytoscape plugin to create a visual semantic summary of networks
Oesper, L., Merico, D., Isserlin, R., & Bader, G. D. (2011) · Source Code for Biology and Medicine · doi:10.1186/1751-0473-6-7 · Cited by 173
Lipoproteins, macrophage function, and atherosclerosis: Beyond the foam cell?
Rader, D. J., & Puré, E. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.03.005 · Cited by 167
Genetic variations and treatments that affect the lifespan of the NPC1 mouse
Liu, B., Li, H., Repa, J. J., Turley, S. D., & Dietschy, J. M. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700525-jlr200 · Cited by 160
Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain
Lütjohann, D., Brzezinka, A., Barth, E., Abramowski, D., Staufenbiel, M., von Bergmann, K., Beyreuther, K., Multhaup, G., & Bayer, T. A. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200071-jlr200 · Cited by 158
Self-citationHuman Mincle Binds to Cholesterol Crystals and Triggers Innate Immune Responses
Kiyotake, R., Oh‐hora, M., Ishikawa, E., Miyamoto, T., Ishibashi, T., & Yamasaki, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645234 · Cited by 156
Brott, T. G., Halperin, J. L., Abbara, S., Bacharach, J. M., Barr, J. D., Bush, R. L., Cates, C. U., Creager, M. A., Fowler, S. A., Friday, G. H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820d8c98 · Cited by 147
Lütjohann, D., Stroick, M., Bertsch, T., Kühl, S., Lindenthal, B., Thelen, K., Andersson, U., Björkhem, I., von Bergmann, K., & Fassbender, K. C. (2004) · Steroids · doi:10.1016/j.steroids.2004.03.012 · Cited by 126
Self-citationActivation of Endothelial Toll-Like Receptor 3 Impairs Endothelial Function
Zimmer, S., Steinmetz, M., Asdonk, T., Motz, I., Coch, C., Hartmann, E., Barchet, W., Waßmann, S., Hartmann, G., & Nickenig, G. (2011) · Circulation Research · doi:10.1161/circresaha.111.243246 · Cited by 123
Self-citationThe acute phase response inhibits reverse cholesterol transport
Feingold, K. R., & Grünfeld, C. (2010) · Journal of Lipid Research · doi:10.1194/jlr.e005454 · Cited by 102
Genome-wide landscape of liver X receptor chromatin binding and gene regulation in human macrophages
Pehkonen, P., Welter-Stahl, L., Diwo, J., Ryynänen, J., Wienecke-Baldacchino, A. K., Heikkinen, S., Treuter, E., Steffensen, K. R., & Carlberg, C. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-50 · Cited by 96
Kappus, M. S., Murphy, A. J., Abramowicz, S., Ntonga, V., Welch, C. L., Tall, A. R., & Westerterp, M. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302781 · Cited by 91
Self-citationMethodological considerations for the harmonization of non-cholesterol sterol bio-analysis.
Mackay, D., Jones, P., Myrie, S., Plat, J., & Lütjohann, D. (2014) · Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · doi:10.1016/j.jchromb.2014.02.052 · Cited by 76
Self-citationTaylor, A. M., Liu, B., Mari, Y., Liu, B., & Repa, J. J. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m028241 · Cited by 70
Hydroxypropyl-β-cyclodextrin-mediated Efflux of 7-Ketocholesterol from Macrophage Foam Cells
Kritharides, L., Kus, M. L., Brown, A. J., Jessup, W., & Dean, R. T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27450 · Cited by 66
Olofsson, P. S., Jatta, K., Wågsäter, D., Gredmark, S., Hedin, U., Paulsson‐Berne, G., Söderberg‐Nauclér, C., Hansson, G. K., & Sirsjö, A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000170130.85334.38 · Cited by 62
Liver X receptor modulators: a review of recently patented compounds (2007 – 2009)
Li, X., Yeh, V. S. C., & Molteni, V. (2010) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543771003621269 · Cited by 54
Coordinating calcium signalling
Minton, K. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3761 · Cited by 53
Cholesterol crystal-induced endothelial cell activation is complement-dependent and mediated by TNF
Nymo, S. H., Niyonzima, N., Espevik, T., & Mollnes, T. E. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.06.006 · Cited by 47
Self-citationMacKay, D., & Jones, P. J. H. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328353292e · Cited by 40
Influence of rifampin on serum markers of cholesterol and bile acid synthesis in men
Lütjohann, D., Hahn, C., Prange, W., Sudhop, T., Axelson, M., Sauerbruch, T., von Bergmann, K., & Reichel, C. (2004) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp42307 · Cited by 39
Self-citationLiu, S. M., Cogny, A., Kockx, M., Dean, R. T., Gaus, K., Jessup, W., & Kritharides, L. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200464-jlr200 · Cited by 35
Hewing, B., & Fisher, E. A. A. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.660143 · Cited by 32
Cited by
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Self-citationOuimet, M., Barrett, T. J., & Fisher, E. A. (2019) · Circulation Research · doi:10.1161/circresaha.119.312617 · Cited by 761
Macrophages in Atherosclerosis Regression
Barrett, T. J. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312802 · Cited by 628
Defective cholesterol clearance limits remyelination in the aged central nervous system
Cantuti-Castelvetri, L., Fitzner, D., Bosch-Queralt, M., Weil, M.-T., Su, M., Sen, P., Ruhwedel, T., Mitkovski, M., Trendelenburg, G., Lütjohann, D., et al. (2018) · Science · doi:10.1126/science.aan4183 · Cited by 586
Self-citationAcute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment
Crea, F., & Libby, P. (2017) · Circulation · doi:10.1161/circulationaha.117.029870 · Cited by 476
Metadata
- Authors
- Zimmer, S., Grebe, A., Bakke, S. S., Bode, N., Halvorsen, B., Ulas, T., Skjelland, M., De Nardo, D., Labzin, L. I., Kerksiek, A., Hempel, C., Heneka, M. T., Hawxhurst, V., Fitzgerald, M. L., Trebicka, J., Björkhem, I., Gustafsson, J.-Å., Westerterp, M., Tall, A. R., Wright, S. D., Espevik, T., Schultze, J. L., Nickenig, G., Lütjohann, D., & Latz, E.
- Venue
- Science Translational Medicine
- Published
- 2016-04-06
- Volume
- 8
- Issue
- 333
- Pages
- 333ra50-333ra50
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2330691955
- Cited by
- 360
- References
- 60
- FWCI
- 42.82
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.